19-44891486-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001128917.2(TOMM40):c.71G>A(p.Gly24Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000428 in 1,354,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001128917.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOMM40 | NM_001128917.2 | c.71G>A | p.Gly24Glu | missense_variant | 1/9 | ENST00000426677.7 | NP_001122389.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOMM40 | ENST00000426677.7 | c.71G>A | p.Gly24Glu | missense_variant | 1/9 | 1 | NM_001128917.2 | ENSP00000410339 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152014Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000718 AC: 2AN: 27862Hom.: 0 AF XY: 0.0000580 AC XY: 1AN XY: 17236
GnomAD4 exome AF: 0.000452 AC: 543AN: 1202222Hom.: 0 Cov.: 30 AF XY: 0.000409 AC XY: 240AN XY: 586734
GnomAD4 genome AF: 0.000243 AC: 37AN: 152014Hom.: 0 Cov.: 33 AF XY: 0.000229 AC XY: 17AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.71G>A (p.G24E) alteration is located in exon 2 (coding exon 1) of the TOMM40 gene. This alteration results from a G to A substitution at nucleotide position 71, causing the glycine (G) at amino acid position 24 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at